Masimo (MASI) Stock Price, News & Analysis

+3.49 (+2.89%)
(As of 05/17/2024 ET)
Today's Range
50-Day Range
52-Week Range
1.15 million shs
Average Volume
612,308 shs
Market Capitalization
$6.59 billion
P/E Ratio
Dividend Yield
Price Target

Masimo MarketRank™ Stock Analysis

Analyst Rating
2.43 Rating Score
11.8% Upside
$138.71 Price Target
Short Interest
7.97% of Float Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
0.48mentions of Masimo in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$5.45 M Sold Last Quarter
Proj. Earnings Growth
From $3.64 to $3.92 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.63 out of 5 stars

Medical Sector

75th out of 923 stocks

Electromedical Equipment Industry

2nd out of 20 stocks

MASI stock logo

About Masimo Stock (NASDAQ:MASI)

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as,, and Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

MASI Stock Price History

MASI Stock News Headlines

Masimo: Promising Developments
See More Headlines
Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Electromedical equipment
Health Care Equipment
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
7 Analysts


Net Income
$81.50 million
Pretax Margin


Sales & Book Value

Annual Sales
$2.05 billion
Cash Flow
$6.16 per share
Book Value
$25.72 per share


Free Float
Market Cap
$6.59 billion

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

MASI Stock Analysis - Frequently Asked Questions

Should I buy or sell Masimo stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last twelve months. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MASI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MASI, but not buy additional shares or sell existing shares.
View MASI analyst ratings
or view top-rated stocks.

What is Masimo's stock price target for 2024?

7 equities research analysts have issued 12 month price objectives for Masimo's stock. Their MASI share price targets range from $86.00 to $170.00. On average, they anticipate the company's stock price to reach $138.71 in the next year. This suggests a possible upside of 11.8% from the stock's current price.
View analysts price targets for MASI
or view top-rated stocks among Wall Street analysts.

How have MASI shares performed in 2024?

Masimo's stock was trading at $117.21 at the start of the year. Since then, MASI stock has increased by 5.9% and is now trading at $124.10.
View the best growth stocks for 2024 here

When is Masimo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024.
View our MASI earnings forecast

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) released its quarterly earnings data on Tuesday, May, 7th. The medical equipment provider reported $0.77 EPS for the quarter, beating analysts' consensus estimates of $0.71 by $0.06. The medical equipment provider had revenue of $492.80 million for the quarter, compared to analyst estimates of $487.70 million. Masimo had a net margin of 4.01% and a trailing twelve-month return on equity of 13.26%. The business's revenue was down 12.8% compared to the same quarter last year. During the same period last year, the business posted $0.87 EPS.

What guidance has Masimo issued on next quarter's earnings?

Masimo updated its second quarter 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share guidance of 0.730-0.790 for the period, compared to the consensus estimate of 0.770. The company issued revenue guidance of $480.0 million-$510.0 million, compared to the consensus revenue estimate of $503.8 million.

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo Chief Executive Officer Joe E. Kiani on Joe E. Kiani has an approval rating of 90% among the company's employees.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

Who are Masimo's major shareholders?

Masimo's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.61%), Westfield Capital Management Co. LP (1.30%), Sumitomo Mitsui Trust Holdings Inc. (0.74%), Bamco Inc. NY (0.65%), Jackson Square Partners LLC (0.56%) and Raymond James & Associates (0.34%). Insiders that own company stock include Adam Mikkelson, Craig B Reynolds, Joe E Kiani, Micah W Young and Tao Levy.
View institutional ownership trends

How do I buy shares of Masimo?

Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MASI) was last updated on 5/18/2024 by Staff

From Our Partners